July 27, 2021 at 6:30 AM EDTPDF Version Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif., July 27, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The... Read more
July 14, 2021 at 8:01 AM EDTPDF Version Million-Cell Experiments Routinely Accessible for the First Time PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis.... Read more
June 10, 2021 at 8:01 AM EDTPDF Version Fueling Discovery in Preserved Tissue Samples to Advance Clinical Translational Research PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the... Read more
April 1, 2021 at 8:30 AM EDTPDF Version Along with recent release of CellPlex, product increases access through affordability PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced the launch of its Chromium Single Cell Gene Expression Low Throughput (LT) Kit, a new offering designed to put the power of... Read more
Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms: Chromium Single... Read more
April 2, 2020 at 9:00 AM EDTPDF VersionFormer Genomic Health CEO brings decades of healthcare experience to Board PLEASANTON, Calif., April 02, 2020 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced the appointment of Kim Popovits, former Chairman of the Board, President and Chief Executive Officer of Genomic Health, Inc., to the company’s Board of Directors. She brings... Read more
February 24, 2020 at 12:00 PM ESTPDF VersionShips Chromium Connect; Unveils Dozen New Applications to Advance Genomics PLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced a broad range of new products at the Advances in Genome Biology and Technology (AGBT) General Meeting, as well as new capabilities for existing products. Today’s... Read more
Date: 09/11/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has filed a patent infringement suit against 10X Genomics, Inc. in the United States District Court for the District of Delaware. In the lawsuit Bio-Rad asserts that 10X Genomics infringes... Read more
ate: 07/24/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announces that today the Delaware District Court granted Bio-Rad’s motion for permanent injunction against 10X Genomics from making any sales of infringing products to new customers and granting Bio-Rad’s request for supplemental damages and... Read more
Stakes Claim in Emerging Spatial Genomics Space PLEASANTON, CA.—December 10, 2018—10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight... Read more